The TGF-βR1 inhibitor galunisertib re-shapes the PDAC-TME by limiting decidual-like natural killer cells polarization
Martina Cucchiara(University of Insubria), Antonino Bruno(University of Insubria), G. Nappo(Humanitas University), A. Pessi(MultiMedica), Pier Francesco Ferrucci(MultiMedica), Annalisa Grimaldi(University of Insubria), Daniele Mercatelli(University of Bologna), Patrizia Borsotti(Mario Negri Institute for Pharmacological Research), Andrea Resovi(Mario Negri Institute for Pharmacological Research), Paola Muti(Department of Public Health), Marta Tagliabue(European Institute of Oncology), Dorina Belotti(Mario Negri Institute for Pharmacological Research), Riccardo Ricotta(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Nicoló Baranzini(University of Insubria), Lorenzo Mortara(University of Insubria), Maria Teresa Palano(University of Milan), Maria Gemelli(MultiMedica), Francesco Acquati(University of Insubria), Giulia Garattini(Mario Negri Institute for Pharmacological Research), Barbara Bassani(MultiMedica), Gianpiero Catalano(MultiMedica), Federica Di Leva(Mario Negri Institute for Pharmacological Research), Cristian Rubuano(MultiMedica), Alessandro Zerbi(Humanitas University), Silvia Uccella(University of Insubria), Gianluca De Antoni(University of Insubria), Matteo Gallazzi(MultiMedica)
Cited by 1
Related Papers
Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma
|Cell Metabolism|2018|420
Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies
|The Lancet Oncology|2013|403
Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy
|Frontiers in Immunology|2018|400